Reaction

Pancreatic Duct Dilatation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 271 reports · 3 co-occurring drugs

As of the last recalculation, Pancreatic Duct Dilatation appears in 271 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (PRR 49.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dorzolamide Hydrochloride And Timolol Maleate549.549.5
Pancrelipase1940.640.6
Irinotecan Hydrochloride636.636.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.